100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Pain relief Dzire SP 100mg/325mg/15mg Tablet relieves pain, reduce swelling and ease inflammation in conditions like rheumatoid arthritis, osteoarthritis and ankylosing spondolytis. It also helps to manage short term symptoms such as muscle and back pain, toothache, or pain in the ear and throat if taken when the first sign of pain occurs. Dzire SP 100mg/325mg/15mg Tablet also reduces fever associated with various painful conditions within 1-2 hour of taking a dose. This medicine also contains an active ingredient called Serratiopeptidase, which is an enzyme that promotes the overall healing process and speeds up recovery. Take it as prescribed to get the most benefit.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Dzire SP 100mg/325mg/15mg Tablet is to be taken with food.
Dzire SP 100mg/325mg/15mg Tablet is a combination of three medicines: Nimesulide, Paracetamol and Serratiopeptidase. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation, and promotes healing.
Unsafe: Avoid consuming alcohol with Dzire SP 100mg/325mg/15mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Information regarding the use of Dzire SP 100mg/325mg/15mg Tablet during pregnancy is not available. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Dzire SP 100mg/325mg/15mg Tablet during breastfeeding is not available. Doctor consultation is advised.
Seek medical advice from your doctor: It is not known whether Dzire SP 100mg/325mg/15mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Caution Advised: Dzire SP 100mg/325mg/15mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Dzire SP 100mg/325mg/15mg Tablet may be needed. Doctor consultation is advised. Use of Dzire SP 100mg/325mg/15mg Tablet is not recommended in patients with severe kidney disease.
Seek medical advice from your doctor: There is limited information available on the use of Dzire SP 100mg/325mg/15mg Tablet in patients with liver disease. Doctor consultation is advised.
If a dose of Dzire SP 100mg/325mg/15mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Satellite Anand Nagar, Ahmedabad, Gujarat
European Medicine Agency. Nimesulide; 2004 (02 Apr. 2019)
Bhagat S, Agarwal M, Roy V. Serratiopeptidase: A systematic review of the existing evidence. Int J Surg. 2013;11(3):209-17 (02 Apr. 2019)
ScienceDirect. Nimesulide (02 Apr. 2019)
ScienceDirect. Paracetamol (02 Apr. 2019)
PubChem. Serratiopeptidase (02 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.